Janux Therapeutics Inc（JANX）價格預測JANXJanux Therapeutics Inc

Alphio's JANX stock price prediction model matches the current Janux Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $18.03 (-0.01%). The 1-week path is $18.16 (+0.72%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, Janux Therapeutics Inc is not a strong buy due to mixed signals from recent earnings and analyst ratings. The current price is $18.03, which is below the average analyst price target of $35, indicating potential upside. However, the company reported a disappointing Q2 EPS of -$0.35, missing expectations by $0.09, and has a negative net income of -$21,972,000 for Q2 2026, which raises concerns about profitability. The RSI is at 55.348, suggesting the stock is neither overbought nor oversold, and the recent 5-day change is +3.68%, showing some positive momentum. However, hedge funds are selling, with a 575.67% increase in selling activity over the last quarter, indicating a lack of confidence among institutional investors. Therefore, while there is potential for growth, the risks associated with current financial performance and market sentiment suggest holding rather than buying at this time.

Janux Therapeutics Inc (JANX) last closed at $18.03, losing -3.99%. These facts feed the 1-day and 1-week JANX price prediction above.